SEARCH   
MEMBER LOGIN    

Equine Pharmaceuticals Manufacturing in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Equine Pharmaceuticals Manufacturing Market Research Report | Life Sciences | Animal Health | Dec 2011

Riding on: Demand will pick up as interest in equestrian sports and horseracing rises

The Equine Pharmaceuticals Manufacturing market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

Report Snapshot
Market Share of Companies
Bayer AG Bayer AG market share
Merck and Co. Inc. Merck and Co. Inc. market share
Pfizer Inc. Pfizer Inc. market share
Sanofi-Aventis U.S. LLC Sanofi-Aventis U.S. LLC market share
Industry Statistics & Market Size
Revenue
$345m
 Annual Growth 06-11
-3.3%
 Annual Growth 11-16
Purchase to read more
Profit
Purchase to read more
 Employment
1,290
 Businesses
57
Industry Analysis & Industry Trends

Riding on

The Equine Pharmaceuticals Manufacturing industry will face improved conditions over the next five years, as renewed demand for equestrian sports and horseracing facilitate revenue growth. Since the industry's largest players are large pharmaceutical manufacturers that also produce non-veterinary products, M&A activity will characterize many companies over the next five years.... purchase to read more

Industry Report - Starting a New Business Chapter

The Equine Pharmaceuticals Manufacturing industry has medium barriers to entry. One potential barrier to entry is the moderate degree of market share concentration. Major players such as Pfizer and Sanofi-Aventis operate on a global scale and command significant market strength on an international and local basis. These companies benefit from economies of scale and established brand names. Another potential barrier to entry is the high capital expenditure required at the onset to establish a manufacturing plant geared to producing these pharmaceutical products. The time factor is another obstacle: developing a production from conception is a lengthy process for new entrants, representing another barrier to entry... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Equine Pharmaceuticals Manufacturing Industry?

This industry comprises companies that manufacture livestock pharmaceuticals specifically for horses. These medications include vaccinations, anti-inflammatories, sedatives, antibiotics and medications to control parasites.

Industry Products
Parasite control productsVaccinesAntibioticsJoint injectionsDigestives
 
Industry Activities
Manufacturing equine sedatives and analgesicsManufacturing equine dressings and wound treatmentsManufacturing equine pharmaceuticals that control worms and other parasitesManufacturing vaccines for equines


View Sample
Quote
Select Clients